Influenza Virus Vaccine 2002-2003
A to Z Drug Facts
Influenza Virus Vaccine 2002-2003 |
(in-flew-EN-zuh virus vaccine) |
FluShield |
Injection (purified split-virus): 15 mcg each: A/Panama/2007/99 (H3N2) (A/Moscow/10/99[H3N2]-like), A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like per 0.5 mL. |
Fluvirin |
Injection (purified split-virus): 15 mcg each: A/Panama/2007/99 (H3N2) (A/Moscow/10/99[H3N2]-like), A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like per 0.5 mL. |
Fluzone |
Injection (purified split-virus): 15 mcg each: A/Panama/2007/99 (H3N2) (A/Moscow/10/99[H3N2]-like), A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like per 0.5 mL. |
Fluviral |
Fluviral S/F |
Vaxigrip |
Class: Vaccine, inactivated virus |
Action Induces formation of specific antibodies that protect against those strains of virus from which vaccine is prepared or to closely related strains.
Indications Induction of active immunity against influenza A and B viruses corresponding to strains in current-year vaccine formula; prophylaxis for people at least 6 mo at increased risk of complications or exposure to influenza. Fluvirin is not indicated for children under 4 yr.
Contraindications Immediate hypersensitivity to product or other components; hypersensitivity to eggs or egg products; delayed immunization is recommended for people with active neurologic disorder characterized by changing neurologic findings; defer immunization during acute respiratory disease or other active infection or during acute febrile illness.
ADULTS AND CHILDREN AT LEAST 9 YR: IM 0.5 mL 1 dose. CHILDREN 3 TO 8 YR: IM 0.5 mL 1 dose; however, if previously unvaccinated, give 2 doses at least 1 mo apart, administering the second dose before December if possible. CHILDREN 6 TO 35 MO: IM 0.25 mL 1 dose; however, if previously unvaccinated, give 2 doses at least 1 mo apart, administering the second dose before December if possible.
Anticoagulants: As with other IM drugs, give with caution to patients receiving anticoagulant therapy. Immunosuppressant drugs (eg, high-dose corticosteroids), radiation therapy: May result in inadequate response to immunization. Pertussis vaccine: In order to attribute causality of adverse reactions, do not give influenza vaccine within 3 days of pertussis vaccination. Theophylline: Theophylline levels may be increased during first 24 hr following vaccination.
Lab Test Interferences None well documented.
Soreness at injection site; fever; malaise; myalgia; Guillain-Barré syndrome; immediate (probably allergic) reactions (eg, hives, angioedema, allergic asthma, systemic anaphylaxis) occur extremely rarely.
Pregnancy: Category C. Lactation: Influenza vaccine does not affect the safety of breastfeeding for mothers or infants. Children: Safety and efficacy not established in children less than 6 mo. Safety and efficacy of Fluvirin in children less than 4 yr not established.
PATIENT CARE CONSIDERATIONS |
|
Books@Ovid
Copyright © 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts